152 related articles for article (PubMed ID: 3753622)
1. Superficial mycoses. Therapeutic agents and clinical applications.
Griffith ML; Flowers FP; Araujo OE
Postgrad Med; 1986 Jan; 79(1):151-6, 161. PubMed ID: 3753622
[No Abstract] [Full Text] [Related]
2. Therapy of superficial fungal infection.
Jones HE
Med Clin North Am; 1982 Jul; 66(4):873-93. PubMed ID: 6285092
[No Abstract] [Full Text] [Related]
3. Haloprogin for tinea.
Med Lett Drugs Ther; 1973 Aug; 15(17):69-70. PubMed ID: 4740517
[No Abstract] [Full Text] [Related]
4. New topical agents for dermatophytosis.
Smith EB
Cutis; 1976 Jan; 17(1):54-8. PubMed ID: 1037098
[TBL] [Abstract][Full Text] [Related]
5. [Antifungal agents].
Bossa R; Galatulas I
Clin Ter; 1981 Oct; 99(1):73-89. PubMed ID: 6458445
[No Abstract] [Full Text] [Related]
6. [Epidermophytoses and Candida mycoses. Treatment and prevention of recurrence].
Meinhof W
Fortschr Med; 1974 Jun; 92(16):673-6. PubMed ID: 4835997
[No Abstract] [Full Text] [Related]
7. Specific drugs for superficial fungus infections.
Lorek M; Maguire H
Am Fam Physician; 1980 Feb; 21(2):164-5. PubMed ID: 6892538
[No Abstract] [Full Text] [Related]
8. Miconazole in the treatment of dermatomycosis.
Thulin H; Osterbye P
Mykosen; 1975 May; 18(5):249-53. PubMed ID: 1160934
[No Abstract] [Full Text] [Related]
9. Antifungal agents.
Warin RP
Practitioner; 1974 Oct; 213(1276 SPEC NO):494-507. PubMed ID: 4617206
[No Abstract] [Full Text] [Related]
10. Current treatment of dermatophytoses.
Hay RJ
Acta Derm Venereol Suppl (Stockh); 1986; 121():117-23. PubMed ID: 2940791
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study with Hoe 296 in glabrous skin dermatophytosis and pityriasis versicolor].
González-Ochoa A; Sarmiento-Cristóbal J; Ortega-Llamas O
Rev Invest Salud Publica; 1974; 34(4):175-81. PubMed ID: 4617272
[No Abstract] [Full Text] [Related]
12. Superficial fungus infections.
Stone OJ; Westburg SP
Am Fam Physician; 1974 Jan; 9(1):163-72. PubMed ID: 4272311
[No Abstract] [Full Text] [Related]
13. [Present state of antimycotic therapy (author's transl)].
Meinhof W
Monatsschr Kinderheilkd (1902); 1979 Apr; 127(4):175-8. PubMed ID: 449874
[TBL] [Abstract][Full Text] [Related]
14. Tolnaftate in the treatment of superficial mycotic infections.
Vibhatavanija T; Phanich V; Thianprasit M; Youngchaiyud U
Southeast Asian J Trop Med Public Health; 1972 Jun; 3(2):277-9. PubMed ID: 4563192
[No Abstract] [Full Text] [Related]
15. [Superficial mycoses in immunosuppressed patients].
Hernanz Hermosa JM; Lázaro Ochaita P
Rev Clin Esp; 1995 Oct; 195 Suppl 3():49-55. PubMed ID: 9441306
[No Abstract] [Full Text] [Related]
16. Topical agents in the treatment of superficial fungal infections.
Winfield JL
Int J Dermatol; 1978 Jun; 17(5):419-22. PubMed ID: 659044
[No Abstract] [Full Text] [Related]
17. Drugs for athlete's foot and tinea cruris.
Med Lett Drugs Ther; 1976 Nov; 18(24):101-2. PubMed ID: 1036605
[No Abstract] [Full Text] [Related]
18. [Our experience with antimycotic therapy with Tolnaftate].
Nunzi E; Carbone G
Minerva Dermatol; 1968 May; 43(5):230-2. PubMed ID: 5705341
[No Abstract] [Full Text] [Related]
19. Clinical evaluation of tolnaftate. A double blind study of a topical antifungal agent.
Kurban AK; Farah FS; Malak JA; Shehadeh NH; Chaglassian HT
Dermatologica; 1966; 133(6):482-6. PubMed ID: 5338033
[No Abstract] [Full Text] [Related]
20. [Multicenter evaluation of the activity and tolerance of a new antimycotic agent: ciclopiroxolamine].
Cattaneo M; Betti R; Lodi A; Masnada MC
G Ital Dermatol Venereol; 1986; 121(6):LXXXI-LXXXV. PubMed ID: 3557531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
